NCT00256880 2017-01-18Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple MyelomaGlaxoSmithKlinePhase 2 Completed100 enrolled
NCT00948961 2016-06-27A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1Celldex TherapeuticsPhase 1/2 Completed70 enrolled